These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 16830805)
21. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating. Jabara R; Chronos N; Robinson K Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646 [TBL] [Abstract][Full Text] [Related]
22. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
23. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of drug-eluting stents: current best available evidence. Raja SG; Dreyfus GD J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969 [TBL] [Abstract][Full Text] [Related]
25. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related]
26. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results. Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205 [TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stents: a pharmacoclinical perspective. Thomas MK; Gupta YK Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106 [TBL] [Abstract][Full Text] [Related]
28. Using ultrasonic spray nozzles to coat drug-eluting stents. Berger HL Med Device Technol; 2006; 17(9):44-6, 48-9. PubMed ID: 17240688 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of controlled drug release from drug-eluting stents. Acharya G; Park K Adv Drug Deliv Rev; 2006 Jun; 58(3):387-401. PubMed ID: 16546289 [TBL] [Abstract][Full Text] [Related]
30. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing. Pendyala L; Jabara R; Robinson K; Chronos N J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521 [TBL] [Abstract][Full Text] [Related]
31. [Anti-restenosis study on a new drug eluting stent]. Zhao A; Zhang H; Huang N; Zhang B; Yang K; Li Z; Zhao H Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):856-9, 878. PubMed ID: 18788296 [TBL] [Abstract][Full Text] [Related]
32. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Beijk MA; Piek JJ Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467 [TBL] [Abstract][Full Text] [Related]
33. An investigation of adhesion in drug-eluting stent layers. Wolf KV; Zong Z; Meng J; Orana A; Rahbar N; Balss KM; Papandreou G; Maryanoff CA; Soboyejo W J Biomed Mater Res A; 2008 Oct; 87(1):272-81. PubMed ID: 18306306 [TBL] [Abstract][Full Text] [Related]
34. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438 [TBL] [Abstract][Full Text] [Related]
35. Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials? Ryan J; Cohen DJ; Pinto DS Coron Artery Dis; 2006 Dec; 17(8):667-71. PubMed ID: 17119374 [TBL] [Abstract][Full Text] [Related]
36. Polymers, drug release, and drug-eluting stents. Commandeur S; van Beusekom HM; van der Giessen WJ J Interv Cardiol; 2006 Dec; 19(6):500-6. PubMed ID: 17107364 [TBL] [Abstract][Full Text] [Related]
37. Local vascular toxicokinetics of stent-based drug delivery. Tesfamariam B Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513 [TBL] [Abstract][Full Text] [Related]
38. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Serruys PW; Daemen J Circulation; 2007 Mar; 115(11):1433-9; discussion 1439. PubMed ID: 17344323 [No Abstract] [Full Text] [Related]
39. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents. Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375 [TBL] [Abstract][Full Text] [Related]
40. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar]. Hansen PR Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]